Testing a new treatment for mild to moderate toenail fungus
Part of Infections, Skin clinical trials.
This trial tests an investigational medication called ATB1651 for people with toenail fungus (onychomycosis). If you have a fungal infection covering 20% to 60% of one or both big toenails and are in generally good health, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have toenail fungus confirmed by a lab test (KOH stain and culture)
- Fungus covers 20% to 60% of one or both big toenails
- The thick part of the infected nail is less than 2 millimeters
- You are between 18 and 70 years old
- You are in good overall health, with no serious medical conditions
- Your BMI is between 17.5 and 35.0
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different treatments for fungus that affects the fingernails or toenails. It is designed to see how well the treatments work and if they are safe.
This trial tests a combination treatment for toenail fungus (onychomycosis). It uses a special device (Mycoclear) and a medicated nail polish (Ciclopirox). It may help if you have mild to moderate fungus on your big toenail.
This study tests a topical antifungal cream (terbinafine) for mild to moderate toenail fungus. It is designed for people who have a fungal infection in one or more toenails but are otherwise healthy.
This trial tests how well and how safely an antifungal gel works for toenail fungus in adults. You may be able to join if your toenail fungus is confirmed with lab tests and you can follow the study rules during the study.
This trial tests a new medication called ZYG24004 for athlete's foot (tinea pedis) caused by specific fungi. It may be a treatment option for people who have not had success with other antifungal treatments.
This trial tests a medicated stick for athlete's foot (tinea pedis). It aims to see if the treatment is safe and works well.
Hear when a new Onychomycosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.